Announcements

First Impact Factor for Translational Pediatrics: 2.286

Published: 2020-06-30

We are pleased to announce that the Translational Pediatrics (TP) has attained its first impact factor update for the 2019 citation year: 2.286.

Translational Pediatrics (Transl Pediatr, TP, Print ISSN 2224-4336, Online ISSN 2224-4344) is an open access, peer-reviewed, bi-monthly journal (quarterly pub-lished from Jul. 2012 - Jul. 2019). The aim of the Journal is to provide a forum for the dissemination of original research articles as well as review articles in all ar-eas related to pediatrics. TP publishes articles in all aspects of health care in newborns, children and adolescents. Contributions pertinent to pediatrics are also included from related fields such as nutrition, surgery, respiration, dentistry, urology, public health, child health services, human genetics, basic sciences, psy-chology, psychiatry, education, sociology, and nursing. Currently, TP has been in-dexed by PubMed/PubMed Central, Scopus and Science Citation Index Expanded (SCIE).

Aiming for the continued development of article quality alongside the growth of the numbers of submissions, we have recently emphasized improving the publi-cation quality and processing transparency. Some significant arrangements were made in TP In the past few months:

1. Integration with Publons. As of April 2020, our publisher AME Publishing Company has entered into an official partnership with Publons. Thus, TP’s peer review system is now integrated seamlessly into the Publons platform (https://publons.com/publisher/6041/ame-publishing-company). The partner-ship allows for the contributions of our expert peer-reviewers to be recognized anytime. For more information, see: http://tp.amegroups.com/announcement/view/3761.

2. Reporting guidelines for original research. For a higher standard of publishing and research quality, we have introduced a series of reporting guidelines for dif-ferent research types. Each original research submission to TP is now required to follow the EQUATOR research reporting guidelines and should include a checklist. If the article is accepted, the related reporting checklist will be pub-lished online with the article. For more details, please check the updated guide-lines for authors: http://tp.amegroups.com/pages/view/guidelines-for-authors.

3. Transparent peer review process. To commit to openness and accountability, and to increase the level of transparency throughout our peer review process, our Editorial Office has decided to implement a transparent peer review process as an option for all manuscripts submitted to TP from March 19, 2020. Click here for further information: http://tp.amegroups.com/announcement/view/3751.

We strive to follow the best practices in publishing. The announcement of the journal’s first impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.

We look forward to the continuous cooperation with all the individuals men-tioned above and those who are interested in thoracic disease to bring more ex-citing content to readers in the coming future.


Editorial Office
Translational Pediatrics (TP)
June 30, 2020